openpharmaA project by Edozie
OPEN INFRASTRUCTURE FOR MEDICINE

Open science.
Accessible
medicine.

Building open tools for pharmaceutical research, evidence and manufacturing. A shared foundation for a future where more people can access the medicine they need.

Explore the modules See the roadmap

Early-stage project. Built in the open.

PLATFORM BLUEPRINTv0.0
+ One connected research stack +
01DiscoveryNew candidates. New possibilities.Drug discovery · Drug repurposing 02EvidenceFrom research question to review.Clinical evidence automation 03ManufacturingUnderstand the cost of making.Cost reduction · Lab in a box Shared datasets & models
All modules planned6 MODULES / 1 MISSION
BUILD STATUS

From zero to 1.0.
Every step, visible.

Overall product completion0%
0%
0 · Prototype starting point100 · Product 1.0

All six modules are at the planning stage. Progress will reflect completed, documented milestones.

THE BUILDING BLOCKS

Six modules.
One open foundation.

Each module has its own Phase 0–5 strategy, acceptance criteria, public changelog and future product portal.

01 / 06
Manufacturing

Manufacturing cost reduction

Make the cost of making medicine visible. Explore equipment, process and production trade-offs in an open cost model.

Planned0%
0% View strategy & roadmap
02 / 06
Infrastructure

Lab in a box

Design a modular research workspace. Bring equipment specifications, workflow software and reproducible experiments together.

Planned0%
0% View strategy & roadmap
03 / 06
Evidence

Clinical evidence automation

Connect the evidence workflow end to end, from literature and protocol drafts to analysis and reporting, with expert review at each decision.

Planned0%
0% View strategy & roadmap
04 / 06
Discovery

Drug discovery engine

Explore promising research directions with transparent models. Connect targets, molecular data and computational screening in one workflow.

Planned0%
0% View strategy & roadmap
05 / 06
Discovery

Drug repurposing engine

Investigate new research uses for existing medicines. Map drug, target and disease evidence to surface hypotheses worth testing.

Planned0%
0% View strategy & roadmap
06 / 06
Shared foundation

Datasets & models library

Give others a starting point they can reproduce. Catalogue datasets, models and experiments with provenance, licences and setup instructions.

Planned0%
0% View strategy & roadmap

These are planned capabilities. Research outputs will need appropriate expert review and experimental validation.

THE ROAD TO 1.0

Build. Test. Reproduce.

Six phases from product 0 to 1.0. Each module defines the work and acceptance criteria behind these milestones.

  1. 0%
    PHASE 0 WE ARE HERE

    Scope & starting point

    Define the question, scope and acceptance criteria.

  2. 20%
    PHASE 1

    Data & foundations

    Pin inputs, sources and reproducibility requirements.

  3. 40%
    PHASE 2

    Working prototype

    Build one usable workflow from input to output.

  4. 60%
    PHASE 3

    Independent benchmarks

    Evaluate held-out cases and publish limitations.

  5. 80%
    PHASE 4

    Partner pilot

    Test the workflow with qualified partners.

  6. 100%
    PHASE 5

    Product 1.0

    Release supported tools with maintenance plans.

Phase 0 is the starting point at 0%; Phase 5 is product 1.0 at 100%. Publishing plans does not advance product completion. Percentages represent development milestones, not clinical validation or regulatory approval. Overall progress is the equal-weight average of the six modules.

WHY OPENPHARMA

Medicine is essential.
Access should be, too.

OpenPharma starts with a question: what becomes possible when the tools behind medicine are easier to inspect, reproduce and improve?

The ambition is more accessible medicine. The work starts with open software, transparent methods and a public record of what works, what fails and what comes next.

Follow the work
BUILDING IN PUBLIC

The public build log.

A capstone project by Edozie. Follow the decisions, experiments and milestones from the first prototype onward.

Code fork
Datasets & models library

OpenPharma RDKit fork created

Created a public code fork of rdkit/rdkit with the upstream BSD 3-Clause licence retained. This establishes a software starting point; no dataset mirror, benchmark result or completed product milestone is claimed.

View the published artifact ↗

Code fork
Datasets & models library

OpenPharma DeepChem fork created

Created a public code fork of deepchem/deepchem with its upstream MIT licence retained. No OpenPharma model training, dataset mirroring or benchmark validation has been completed.

View the published artifact ↗

Planning
Drug discovery engine

Phase 0–5 strategy and portal plan published

Published the module strategy, concrete phase deliverables, acceptance criteria and future portal workflow. This is a planning update; product completion remains 0%.

View the public changelog